Pricing Log in Create free account
Friday 6 November 2026 Export TGTX’s income statement to Excel — free account

TG Therapeutics, Inc.

TGTX Healthcare Biotechnology

TG Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $616.3 million, up 87.3% from fiscal 2024.

Revenue
+70.3%
EPS
−73.7%
Free cash flow
+427.1%
Total debt
+204.2%

Quarter to June 2026, against a year earlier

58.51 0.53 +0.91%
Market cap
$8.9B
P/E
19.1×
Fwd P/E
62.4×
Dividend yield
—
F-score
5/9
Altman Z
6.29
Beneish M
0.80
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

TG Therapeutics, Inc. (TGTX) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, TG Therapeutics, Inc. (TGTX) trades at a EV/Sales of 10.5×. Over the past ten years it has ranged from 4.3× (October 2023) to 41,568× (December 2020); the current reading is higher than 18% of that period. That is above the Biotechnology industry median of 9.0× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 7.2× (45.40%)
FY2024 13.1× 32.89%
FY2023 9.9× (98.14%)
FY2022 530× 56.62%
FY2021 339× (99.05%)
FY2020 35,702× 522.88%
FY2019 5,732× 262.07%
FY2018 1,583× (47.52%)
FY2017 3,017× 164.33%
FY2016 1,141× (62.79%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 10.0× 39.02%
Mar 2026 7.2× 0.44%
Dec 2025 7.2× (29.16%)
Sep 2025 10.1× (13.12%)
42 more quarters

Against its own ten years

Low 4.3× High 41,568×
Ten-year median 1,690×
Current reading's percentile 19

EV/Sales against peers

Company EV/Sales
CAI Caris Life Sciences,�Inc. compare 6.8×
MDGL Madrigal Pharmaceuticals, Inc. compare 7.8×
TGTX TG Therapeutics, Inc. 10.5×
KRYS Krystal Biotech, Inc. compare 17.0×
TWST Twist Bioscience Corporation compare 17.3×
PTGX Protagonist Therapeutics, Inc. compare 28.9×
IBRX ImmunityBio, Inc. compare 56.5×
CYTK Cytokinetics, Incorporated compare 65.9×
SYRE Spyre Therapeutics, Inc. compare 7,143×
Biotechnology industry median 9.0×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on TGTX